LncRNA FEZF1‐AS1 binds to EZH2 and LSD1 promoters, epigenetically suppressing the expression of E‐cadherin and activating the Wnt/β‐catenin signalling pathway in NSCLC cells.151. Here, EZH2 is linked to non-small cell lung carcinoma.